MyotonPRO Digital Palpation Device was successfully launched to the ISS, on 2nd April 2018 20:30UTC, from SLC-40 of Cape Canaveral. Launch vehicle - SpaceX Falcon 9 rocket, spacecraft Dragon CRS-14. It is important milestone in better understanding of the muscle physiology. Due to absence of suitable technology (non-invasive, in-vivo), the muscle tone and bio-mechanical properties of a muscle tissue have never been measured in space before. MyotonPRO device is designed to function in different gravity environments from zero G to hypergravity 1.3G. Experiment objectives: Investigators aim to access microgravity-induced biomechanical muscle parameters such as tone, tension, stiffness, elasticity, relaxation and creep on the relaxed skeletal muscles of the human body. More over the aim is better to understand muscle physiology and improve objective monitoring of muscle health and physical condition of crewmembers during pre-flight training, in-flight activities, and post-flight reconditioning. Mentioned properties will be measured with the non-invasive MyotonPRO© Digital Palpation Device. Specific aims:
- To better understand the fundamental adaptation mechanisms related to the yet ill-defined structure-function-biomechanics interrelations of the human resting myofascial system exposed to long-term continuous microgravity.
- To gain a better and more comprehensive evaluation of the crewmembers performance control and fitness for variable mission duties (inflight monitoring).
- To perform routine monitoring on crewmembers before launch and after landing.
- To monitor in relation to preflight data the magnitude of changes throughout the full cycle of deconditioning on the International Space Station (ISS) and post-flight reconditioning.
- To monitor on which level due to regular exercise the astronauts will be able to maintain and even up the parameters measured by the MyotonPRO© on Earth versus on the ISS.
- To monitor the microgravity changes of different tissue and muscle types.